Polaris Management Co. VII, L.L.C., Ten Percent Owner at Metacrine, holds 1.11M shares in CAMP4 Therapeutics Corporation (Ticker: CAMP), holds 2.55M shares in SQZ Biotechnologies (Ticker: SQZB), holds 178.94K shares in Metacrine (Ticker: MTCR). Most recently, Polaris Management Co. VII, L.L.C. Bought ― shares of CAMP4 Therapeutics Corporation on Sep 11, 2025 for an estimated value of $2.00M.
What was Polaris Management Co. VII, L.L.C.’s latest transaction?
Polaris Management Co. VII, L.L.C. latest transaction was an Informative Buy of $2.00M.
What was Polaris Management Co. VII, L.L.C.'s most profitable transaction?
Polaris Management Co. VII, L.L.C.’s most profitable transaction was an Informative Buy of SQZB stock on November 3, 2020. The return on the trade was -14.60%.
What is Polaris Management Co. VII, L.L.C.'s role in Metacrine?
Polaris Management Co. VII, L.L.C.'s role in Metacrine is Ten Percent Owner.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.